Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05632770 · ClinicalTrials.gov registry record · NA

A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems

A NA study of PTSD and Physical Injury, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
424
Enrollment target
1
Study location

NCT05632770: Recruiting NA study of PTSD and Physical Injury, sponsored by University of Washington.

NCT05632770 is a NA study of PTSD and Physical Injury that is actively recruiting participants, run by University of Washington. The registered enrollment target is 424 participants, above the 299-participant average among 154 other PTSD trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05632770, a NA study of PTSD and Physical Injury, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
424 participants
Enrollment target
1
Study location

Study Summary

This investigation is a randomized pragmatic trial of a brief stepped care intervention delivered from an acute care medical trauma center that may both reduce the symptoms of posttraumatic stress disorder (PTSD) and diminish emergency department health service utilization.

Primary Outcome

The investigators will use the DSM-5 PTSD Checklist (PCL-5) and DSM-IV PTSD Checklist (PCL-IV). The scoring of the PCL-5 scale ranges from a minimum of 0 to a maximum of 80, with higher scores indicating a worse outcome. The measure can also provide a rating of symptoms consistent with a diagnosis of PTSD.

Conditions Studied

Interventions

  • BEHAVIORAL Stepped Collaborative Care
  • BEHAVIORAL American College of Surgeons (ACS) Required Screening and Referral (Usual Care)

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 424 participants
Start Date 2023-01-09
Est. Completion 2027-10-31
Phase NA
University of Washington

1,048 total trials

What NCT05632770 shows while recruiting

NCT05632770 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, above the 299-participant average among 154 other PTSD trials with a reported enrollment target (42% higher).

The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Stepped Collaborative Care is the first listed.

NCT05632770 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT05632770 about?

NCT05632770 is a clinical study titled "A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems". This investigation is a randomized pragmatic trial of a brief stepped care intervention delivered from an acute care medical trauma center that may both reduce the symptoms of posttraumatic stress disorder (PTSD) and diminish emergency department health service utilization.

What is the current status of trial NCT05632770?

This trial is currently recruiting. It is a NA study. The enrollment target is 424 participants. The study started on 2023-01-09. Estimated completion is 2027-10-31.

What conditions does trial NCT05632770 study?

This clinical trial studies the following conditions: PTSD, Physical Injury.

What interventions are being tested in trial NCT05632770?

The interventions under investigation include: Stepped Collaborative Care (BEHAVIORAL), American College of Surgeons (ACS) Required Screening and Referral (Usual Care) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05632770?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05632770 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05632770's enrollment target sits among peer trials

424 11th of 154 higher than 144 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05733767 · 424 participants · Phase 2

    Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

  • NCT06978127 · 424 participants · NA

    Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

  • NCT07140913 · 424 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  • NCT07197827 · 424 participants · Phase 1

    A Study of YL242 in Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05632770, the US trial registry maintained by the National Library of Medicine. NCT05632770 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.